Indonesia Volcano Belches Ash Tower as Highest Alert Issued

Lava rises from Mount Etna, Italy March 20, 2025. REUTERS/Etna Walk/Marco Restivo
Lava rises from Mount Etna, Italy March 20, 2025. REUTERS/Etna Walk/Marco Restivo
TT
20

Indonesia Volcano Belches Ash Tower as Highest Alert Issued

Lava rises from Mount Etna, Italy March 20, 2025. REUTERS/Etna Walk/Marco Restivo
Lava rises from Mount Etna, Italy March 20, 2025. REUTERS/Etna Walk/Marco Restivo

A volcano in eastern Indonesia erupted late Thursday, sending a dark ash tower eight kilometers (nearly five miles) into the sky as officials raised the alert level to its highest, AFP reported.

Mount Lewotobi Laki-Laki, a 1,703-meter (5,587-foot) twin-peaked volcano on the tourist island of Flores, erupted for 11 minutes and nine seconds, authorities said.

"The ash column was observed grey to black with thick intensity," Indonesia's volcanology agency said in a statement about the eruption that began at 22:56 pm (1456 GMT).

There were no immediate reports of damages to nearby villages, but the agency warned residents of the potential for volcanic mudflow due to heavy rainfall.

The long eruption prompted the country's geological agency to raise the volcano's alert level to the highest of the four-tiered system.

Authorities imposed an exclusion zone between seven and eight kilometers around the volcano, the agency added.

In November, Mount Lewotobi Laki-Laki erupted multiple times, killing nine people, cancelling scores of international flights to the tourist island of Bali and forcing thousands to evacuate.

Laki-Laki, which means "man" in Indonesian, is twinned with a calmer volcano named after the Indonesian word for "woman".

Indonesia, a vast archipelago nation, experiences frequent seismic and volcanic activity due to its position on the Pacific "Ring of Fire."



Stem Cell Treatment Helped Improve Spinal Cord Injuries, Say Japan Scientists

A scientific researcher extracts the RNA from embryonic stem cells in a laboratory. (AFP/Getty Images)
A scientific researcher extracts the RNA from embryonic stem cells in a laboratory. (AFP/Getty Images)
TT
20

Stem Cell Treatment Helped Improve Spinal Cord Injuries, Say Japan Scientists

A scientific researcher extracts the RNA from embryonic stem cells in a laboratory. (AFP/Getty Images)
A scientific researcher extracts the RNA from embryonic stem cells in a laboratory. (AFP/Getty Images)

A stem cell treatment helped improve the motor function of two out of four patients with a spinal cord injury in the first clinical study of its kind, Japanese scientists said.

There is currently no effective treatment for paralysis caused by serious spinal cord injuries, which affect more than 150,000 patients in Japan alone, with 5,000 new cases each year.

Researchers at Tokyo's Keio University are conducting their study using induced pluripotent stem cells (iPS) -- created by stimulating mature, already specialized, cells back into a juvenile state.

They can then be prompted to mature into different kinds of cells, with the Keio researchers using iPS-derived cells of the neural stem.

The university said on Friday that the motor function score for two patients improved after an operation to implant more than two million iPS-derived cells into a spinal cord.

No serious adverse event was observed for all four cases after a year of monitoring, the university said.

The research's main goal was to study the safety of injecting the cells.

Public broadcaster NHK reported that one of the two was an elderly man who suffered the injury in an accident.

He is now able to stand without support and has started practicing walking, NHK said.

"We were able to achieve results in the world's first spinal cord treatment with iPS," Hideyuki Okano, a Keio professor who heads the research, said, according to NHK.

Okano said the team hoped to move to a clinical trial that would be a step towards bringing the treatment to patients.

The university received government approval for their initial study in 2019 and they carried out the first operation in 2022.

Details of the patients remain confidential, but the team is focusing on people who were injured 14-28 days before the operation.

The number of cells implanted was determined after safety experiments in animals.